The international medical community is increasingly aware that diabetes is a major global health threat and poses increasing challenges to public health and health systems worldwide. Aim: To compare the results of three national cross-sectional studies on diabetes prevalence in Bulgaria (2006, 2012 and 2024) and to assess the dynamics. Material and Methods: The three studies included 2396, 2033 and 936 subjects respectively. The United Nation / The International Diabetes Federation (2006) diagnostic criteria were applied, and the data were evaluated according to type of settlement and age. Results: Diabetes prevalence was 7.9% in 2006 and 9.55% in 2012 (p = 0.06). This difference is due to the greater rise in men (9.2% to 11.5%, p = 0.09) compared to women (6.9% to 7.7%, NS). In the next period, 2012 - 2024, the prevalence of diabetes in general, as well as the prevalence in men and women increased significantly. (Diabetes in general - from 9.6% to 15.7%, p < 0.001; diabetic men - from 11.5% to 21.2%, p < 0.001; diabetic women – from 7.8% to 10.4%, p < 0.016). The prevalence of diabetes nearly doubled, while the population decreased and its structure, lifestyle and diet changed. Obesity significantly increased over a 18-year period - 2024 vs. 2006 (33.3% vs. 26.7%, p < 0.001). The prevalence of diabetes increased with age, with significant rise in the 30-39 age group for 2012 - 2024, from 1.7% to 4.5% (p < 0.047) and more sharply when comparing 2006 - 2024 – from 0.9% to 4.5% (p < 0.002). There was a similar increase in the next age group. For the age 60-79, the prevalence reached 29.9%, i.e. every third person. As arterial hypertension is significantly more common in diabetics, its role as a risk factor is indisputable. Conclusion: The health care system should be readjusted according to the new reality for early diagnose of diabetes in risk groups and adequate modern care.
| Published in | Clinical Medicine Research (Volume 13, Issue 4) |
| DOI | 10.11648/j.cmr.20241304.12 |
| Page(s) | 45-54 |
| Creative Commons |
This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited. |
| Copyright |
Copyright © The Author(s), 2024. Published by Science Publishing Group |
Diabetes Prevalence, Diabetes Dynamic, Age, Obesity, Diabetes Epidemic
| [1] | WHO. (2019). Classification of diabetes mellitus. |
| [2] | Chan, Juliana C N; Lim, Lee-Ling; Wareham, Nicholas J; Shaw, Jonathan E; Orchard, Trevor J; Zhang, Ping; Lau, Eric S H; Eliasson, Björn et al. The Lancet Commission on diabetes: using data to transform diabetes care and patient lives. Lancet 2021; 396, 10267, P2019–2082. |
| [3] | International Diabetes Federation. (2021). IDF Diabetes Atlas, 10th edn. Brussels: International Diabetes Federation. |
| [4] | WHO. Global action plan for the prevention and control of noncommunicable diseases 2013–2020. Nov 14, 2013. Geneva: World Health Organization. |
| [5] | The GBD 2019 Universal Health Coverage Collaborators. Measuring universal health coverage based on an index of effective coverage of health services in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. The Lancet, 396(10258), 1250-1284. |
| [6] | UN. The Sustainable Development Goals Report 2020. New York, NY: (2020). United Nations. |
| [7] | Pouya Saeedi, Inga Petersohn, Paraskevi Salpea, Belma Malanda, Suvi Karuranga, Nigel Unwin, Stephen Colagiuri, Leonor Guariguata et al. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: results from the International Diabetes Federation Diabetes Atlas, 9th edition. Diabetes Res Clin Pract; (2019). |
| [8] | CDC: Centers for Disease Control and Prevention, National Diabetes Statistics Report, 2024. |
| [9] | Borissova Anna-Maria, Kovatcheva Roussanka, Shinkov Alexander, Atanasova Iliana, Vukov Martcho, Aslanova Nina, Vlahov Jordan, Dakovska Lilia. Cross-sectional study on the prevalence of diabetes mellitus in non-selected Bulgarian population. Endokrinologya 2007; 12: 42–49. ISSN 1310-8131. |
| [10] | Borissova Anna-Maria, Shinkov Alexander, Vlahov Jordan, Dakovska Lilia, Blajeva Emilia, Todorov Todor. Prevalence of diabetes mellitus and prediabetes in Bulgaria today. Endokrinologya 2012; 17: 172–182. ISSN 1310-8131. |
| [11] | Akinbami LJ, Chen TC, Davy O, Ogden CL, Fink S, Clark J, et al National Health and Nutrition Examination Survey, 2017–March 2020 Prepandemic File: Sample Design, Estimation, and Analytic Guidelines. Data Evaluation and Methods Research. NATIONAL CENTER FOR HEALTH STATISTICS. Vital and Health Statisticsр Series 2, Number 190 May 2022. |
| [12] | IDF. Diabetes Atlas. 4th ed. Belgium: International Diabetes Federation; (2009), page 98. ISBN-13: 978-2-930229-71-3. |
| [13] | Ahmad OB, Boschi-Pinto C, Murray CJL, Lozano R, Inoue M. Age Standardization of Rates. A New WHO World Standard 2001. Geneva, Switzerland: WHO (2001). |
| [14] | United Nations, Population Division. World Population Prospects. The 2006 Revision. Geneva: United Nations, Population Division, 2007. |
| [15] | Shaw E, Sicree RA, Zimment PZ. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract. 2010; 87: 4–14. |
| [16] | Anna-Maria Borissova, Alexander Shinkov, Roussanka Kovatcheva, Jordan Vlahov, Lilia Dakovska and Todor Todorov. Changes in the Prevalence of Diabetes Mellitus in Bulgaria (2006–2012). Clinical Medicine Insights: Endocrinology and Diabetes. 2015; Volume 8, pages 41-45. |
| [17] | Anna-Maria Borissova, Alexander Shinkov, Jordan Vlahov, Lilia Dakovska, Todor Todorov. Higher Prevalence of Diabetes Mellitus and Impaired Glucose Tolerance Among the Rural Population in Bulgaria. J Endocrinol Metab. 2016; Volume 6, Number 2, pages 52-58. |
| [18] | Guariguata L, Whiting D, Weil C, Unwin N. The International Diabetes Federation Diabetes Atlas methodology for estimating global and national prevalence of diabetes in adults. Diab Res Clin Pract. 2011; 94: 322–332. |
| [19] | NSI. The population of Bulgarian Republic. National Statistical Institute. 2005. Available at: |
| [20] | NSI. 17th National population census in Bulgaria. National Statistical Institute. 2011. Available at: |
| [21] |
NSI. National population census in Bulgaria. National Statistical Institute. December 2022.
https://www.nsi.bg/sites/default/files/files/publications/StatBook_Census2021.pdf |
| [22] | Jonathan Cimino and Claude Braun. Design a Clinical Research Protocol: Influence of Real-World Setting. Healthcare. 2023; 11, 2254. |
| [23] | International Diabetes Federation. Clinical Guidelines Task Force. Global Guideline for Type 2 Diabetes. Belgium, 2012. |
| [24] | 2023 ESH Guidelines for the management of arterial hypertension. The Task Force for the management of arterial hypertension of the European Society of Hypertension Endorsed by the International Society of Hypertension (ISH) and the European Renal Association (ERA). Authors/Task Force Members: Giuseppe Mancia (Chairperson), Reinhold Kreutz (Co-Chair), Mattias Brunstrom, Michel Burnierd, Guido Grassie, Andrzej Januszewiczf et al. J. of Hypertension. 2023; Vol 41, Number 12. |
| [25] | The Diabetes Control and Complications Trial Research Group: The relationship of glycemic exposure (A1C) to the risk of development and progression of retinopathy in the Diabetes Control and Complications Trial. Diabetes. 1995; 44: 968–983. |
| [26] | World Health Organization. Prevention of Diabetes mellitus. Report of a WHO study group Geneva: World Health Organization. 1994, No 844. PMID: 7941615. |
| [27] | United Nation, International Diabetes Federation. Definition and diagnosis of diabetes mellitus and intermediate hyperglycaemia. Geneva, Switzerland, 2006. |
| [28] | World Health Organization and International Diabetes Federation. Definition and diagnosis of diabetes mellitus and Intermediate hyperglycaemia. Report of a WHO/IDF Consultation, Geneva, 2016. |
| [29] | Borissova Anna-Maria, Vlahov Jordan, Shinkov Alexander, Dakovska Liliа, Trifonova Boiana. A 5-year follow-up of subjects with fasting plasma glucose above 5.6 mmol/l found in a screening study in the Bulgarian population (2012-2017). Clinical Medical Research. 2021; 10(3): 95-101. |
| [30] | Fahed AC, El-Hage-Sleiman AK, Farhat TI, Nemer GM. Diet, genetics, and disease: a focus on the middle East and north Africa region. J Nutr Metab 2012: 109037. |
| [31] | Delpino FM, Figueiredo LM, Bielemann RM, Da Silva BGC, Dos Santos FS, Mintem GC, Flores TR, Arcencio RA, Nunes BP. Ultra-processed food and risk of type 2 diabetes: a systematic review and metaanalysis of longitudinal studies. Int J Epidemiol. 2022; 51(4): 1120–1141. |
| [32] | Lovic D, Piperidou A, Zografou I, Grassos H, Pittaras A, Manolis A. The growing epidemic of diabetes mellitus. Curr Vasc Pharmacol. 2020; 18(2): 104-109. |
| [33] | Khunti K, Valabhji J, Misra S. Diabetes and the COVID-19 pandemic. Diabetologia 2023; Feb 66(2): 255-266. |
| [34] | Popkin BM, Adair LS, Ng SW. Global nutrition transition and the pandemic of obesity in developing countries. Nutr Rev. 2012; 70: 3–21. |
| [35] | National Health and Nutrition Examination Survey 2017–March 2020 Prepandemic Data Files—Development of Files and Prevalence Estimates for Selected Health Outcomes Bryan Stierman, M. D., M. P. H.; Joseph Afful, M. S.; Margaret D. Carroll, M. S. P. H.; Te-Ching Chen, Ph.D.; Orlando Davy, M. P. H.; Steven Fink, M. A.; Cheryl D. Fryar, M. S. P. H.; Qiuping Gu, Ph.D.; Craig M. Hales, M. D., M. P. H.; Jeffery P. Hughes, M. P. H.; Yechiam Ostchega, Ph.D., R. N.; Renee J. Storandt, M. T. (A.S.C.P.), M. S. P. H.; and Lara J. Akinbami, M. D. National Health Statistics Reports, 2021; Number 158 n June 14. |
| [36] | Kautzky-Willer A, Harreiter J, Pacini G. Sex and gender differences in risk, pathophysiology and complications of type 2 diabetes mellitus. Endocr Rev. 2016; 37: 278–316. |
| [37] | John R. Petrie, Tomasz J. Guzik, Rhian M. Touyz. Diabetes, Hypertension, and Cardiovascular Disease: Clinical Insights and Vascular Mechanisms. Canadian Journal of Cardiology. 2018; 34, 575e584. |
| [38] | Akalu Yonas, Belsti Yitaych. Hypertension and its associated factors among type 2 diabetes mellitus patients at debre tabor general hospital, Northwest Ethiopia. Diabetes Metab Syndr Obes. 2020; 13: 1621–31. |
| [39] | Vasilis Tsimihodimos, Clicerio Gonzalez-Villalpando, James B. Meigs, Ele Ferrannini. Hypertension and Diabetes Mellitus Coprediction and Time Trajectories. Hypertension. 2018; 71: 422-428. |
| [40] | Sinclair A, Saeedi P, Kaundal A, Karuranga S, Malanda B, Williams R. Diabetes and global ageing among 65-99-year-old adults: Findings from the International Diabetes Federation Diabetes atlas, 9(th) edition. Diabetes Res Clin Pract. 2020; 162: 108078. |
| [41] | Khan MAB, Hashim MJ, King JK, Govender RD, Mustafa H, Al Kaabi J. Epidemiology of type 2 diabetes - global burden of disease and forecasted trends. J Epidemiol Glob Health. 2020; 10(1): 107–11. |
APA Style
Borissova, A., Trifonova, B., Dakovska, L., Topchieva, N., Vukov, M. (2024). Changes in the Prevalence of Diabetes in Bulgaria over an 18-Year Period (2006-2024). Clinical Medicine Research, 13(4), 45-54. https://doi.org/10.11648/j.cmr.20241304.12
ACS Style
Borissova, A.; Trifonova, B.; Dakovska, L.; Topchieva, N.; Vukov, M. Changes in the Prevalence of Diabetes in Bulgaria over an 18-Year Period (2006-2024). Clin. Med. Res. 2024, 13(4), 45-54. doi: 10.11648/j.cmr.20241304.12
AMA Style
Borissova A, Trifonova B, Dakovska L, Topchieva N, Vukov M. Changes in the Prevalence of Diabetes in Bulgaria over an 18-Year Period (2006-2024). Clin Med Res. 2024;13(4):45-54. doi: 10.11648/j.cmr.20241304.12
Share This Article
Twitter
Linked In
Facebook
Copy
Download@article{10.11648/j.cmr.20241304.12,
author = {Anna-Maria Borissova and Boyana Trifonova and Lilia Dakovska and Neriman Topchieva and Mircho Vukov},
title = {Changes in the Prevalence of Diabetes in Bulgaria over an 18-Year Period (2006-2024)
},
journal = {Clinical Medicine Research},
volume = {13},
number = {4},
pages = {45-54},
doi = {10.11648/j.cmr.20241304.12},
url = {https://doi.org/10.11648/j.cmr.20241304.12},
eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.cmr.20241304.12},
abstract = {The international medical community is increasingly aware that diabetes is a major global health threat and poses increasing challenges to public health and health systems worldwide. Aim: To compare the results of three national cross-sectional studies on diabetes prevalence in Bulgaria (2006, 2012 and 2024) and to assess the dynamics. Material and Methods: The three studies included 2396, 2033 and 936 subjects respectively. The United Nation / The International Diabetes Federation (2006) diagnostic criteria were applied, and the data were evaluated according to type of settlement and age. Results: Diabetes prevalence was 7.9% in 2006 and 9.55% in 2012 (p = 0.06). This difference is due to the greater rise in men (9.2% to 11.5%, p = 0.09) compared to women (6.9% to 7.7%, NS). In the next period, 2012 - 2024, the prevalence of diabetes in general, as well as the prevalence in men and women increased significantly. (Diabetes in general - from 9.6% to 15.7%, p Conclusion: The health care system should be readjusted according to the new reality for early diagnose of diabetes in risk groups and adequate modern care.
},
year = {2024}
}
TY - JOUR T1 - Changes in the Prevalence of Diabetes in Bulgaria over an 18-Year Period (2006-2024) AU - Anna-Maria Borissova AU - Boyana Trifonova AU - Lilia Dakovska AU - Neriman Topchieva AU - Mircho Vukov Y1 - 2024/09/06 PY - 2024 N1 - https://doi.org/10.11648/j.cmr.20241304.12 DO - 10.11648/j.cmr.20241304.12 T2 - Clinical Medicine Research JF - Clinical Medicine Research JO - Clinical Medicine Research SP - 45 EP - 54 PB - Science Publishing Group SN - 2326-9057 UR - https://doi.org/10.11648/j.cmr.20241304.12 AB - The international medical community is increasingly aware that diabetes is a major global health threat and poses increasing challenges to public health and health systems worldwide. Aim: To compare the results of three national cross-sectional studies on diabetes prevalence in Bulgaria (2006, 2012 and 2024) and to assess the dynamics. Material and Methods: The three studies included 2396, 2033 and 936 subjects respectively. The United Nation / The International Diabetes Federation (2006) diagnostic criteria were applied, and the data were evaluated according to type of settlement and age. Results: Diabetes prevalence was 7.9% in 2006 and 9.55% in 2012 (p = 0.06). This difference is due to the greater rise in men (9.2% to 11.5%, p = 0.09) compared to women (6.9% to 7.7%, NS). In the next period, 2012 - 2024, the prevalence of diabetes in general, as well as the prevalence in men and women increased significantly. (Diabetes in general - from 9.6% to 15.7%, p Conclusion: The health care system should be readjusted according to the new reality for early diagnose of diabetes in risk groups and adequate modern care. VL - 13 IS - 4 ER -
Clinic of Endocrinology, University Hospital Sofiamed, Sofia, Bulgaria; Department of Internal Diseases, Faculty of Medicine, Sofia University “Saint. Kliment Ohridski”, Sofia, Bulgaria
Clinic of Endocrinology, University Hospital Sofiamed, Sofia, Bulgaria; Department of Internal Diseases, Faculty of Medicine, Sofia University “Saint. Kliment Ohridski”, Sofia, Bulgaria
Clinic of Endocrinology, University Hospital Sofiamed, Sofia, Bulgaria
Clinic of Endocrinology, University Hospital Sofiamed, Sofia, Bulgaria
Clinic of Endocrinology, University Hospital Sofiamed, Sofia, Bulgaria
